383 related articles for article (PubMed ID: 15940485)
1. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: 12 years' experience.
Kurli M; Finger PT
Graefes Arch Clin Exp Ophthalmol; 2005 Nov; 243(11):1108-14. PubMed ID: 15940485
[TBL] [Abstract][Full Text] [Related]
2. Topical mitomycin chemotherapy for conjunctival malignant melanoma and primary acquired melanosis with atypia: clinical experience with histopathologic observations.
Demirci H; McCormick SA; Finger PT
Arch Ophthalmol; 2000 Jul; 118(7):885-91. PubMed ID: 10900099
[TBL] [Abstract][Full Text] [Related]
3. Topical mitomycin C chemotherapy for conjunctival melanoma and PAM with atypia.
Finger PT; Czechonska G; Liarikos S
Br J Ophthalmol; 1998 May; 82(5):476-9. PubMed ID: 9713051
[TBL] [Abstract][Full Text] [Related]
4. [Management of conjunctival malignant melanoma associated with primary acquired melanosis (PAM) using 0.02% mitomycin C eyedrops].
Groh MJ; Holbach LM; Kühnel B; Conway RM; Naumann GO
Ophthalmologe; 2003 Sep; 100(9):708-12. PubMed ID: 14504895
[TBL] [Abstract][Full Text] [Related]
5. Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex.
Finger PT; Sedeek RW; Chin KJ
Am J Ophthalmol; 2008 Jan; 145(1):124-129. PubMed ID: 17981257
[TBL] [Abstract][Full Text] [Related]
6. The treatment of primary acquired melanosis (PAM) with atypia by topical Mitomycin C.
Pe'er J; Frucht-Pery J
Am J Ophthalmol; 2005 Feb; 139(2):229-34. PubMed ID: 15733981
[TBL] [Abstract][Full Text] [Related]
7. [Mitomycin C in treatment of conjunctival melanoma and primary acquired melanosis].
Werschnik C; Lommatzsch PK
Klin Monbl Augenheilkd; 1998 Jun; 212(6):465-8. PubMed ID: 9715467
[TBL] [Abstract][Full Text] [Related]
8. Role of topical chemotherapy for primary acquired melanosis and malignant melanoma of the conjunctiva and cornea: review of the evidence and recommendations for treatment.
Chalasani R; Giblin M; Conway RM
Clin Exp Ophthalmol; 2006; 34(7):708-14. PubMed ID: 16970772
[TBL] [Abstract][Full Text] [Related]
9. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: complications and recurrences.
Ditta LC; Shildkrot Y; Wilson MW
Ophthalmology; 2011 Sep; 118(9):1754-9. PubMed ID: 21652078
[TBL] [Abstract][Full Text] [Related]
10. Corneal melanosis successfully treated using topical mitomycin-C and alcohol corneal epitheliectomy: a 3-year follow-up case report.
Balcı M; Yağcı R; Güler E; Haltaş H; Duman R; Hepşen İF
Arq Bras Oftalmol; 2015; 78(4):255-6. PubMed ID: 26375344
[TBL] [Abstract][Full Text] [Related]
11. Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Sacu S; Ségur-Eltz N; Horvat R; Lukas JR; Zehetmayer M
Am J Ophthalmol; 2003 Aug; 136(2):375-7. PubMed ID: 12888073
[TBL] [Abstract][Full Text] [Related]
12. Conjunctival melanoma arising from diffuse primary acquired melanosis in a young black woman.
Colby KA; Nagel DS
Cornea; 2005 Apr; 24(3):352-5. PubMed ID: 15778614
[TBL] [Abstract][Full Text] [Related]
13. [The treatment of a primary acquired melanosis of the conjunctiva with atypia by low dose of Mitomycin C 0.02 % - case report with follow up of 2 years].
Schmidt M; Maier M; Schmidt T; Klaehsen D; Merté RL
Klin Monbl Augenheilkd; 2001 Dec; 218(12):805-9. PubMed ID: 11805873
[TBL] [Abstract][Full Text] [Related]
14. [Conjunctival primary acquired melanosis].
Krohn J; Monge OR
Tidsskr Nor Laegeforen; 2005 Sep; 125(18):2480-2. PubMed ID: 16186865
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a short-term topical interferon α-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia.
Garip A; Schaumberger MM; Wolf A; Herold TR; Miller CV; Klingenstein A; Schebitz-Walter K; Hintschich CR
Orbit; 2016; 35(1):29-34. PubMed ID: 26636727
[TBL] [Abstract][Full Text] [Related]
16. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy.
Salomão DR; Mathers WD; Sutphin JE; Cuevas K; Folberg R
Ophthalmology; 1999 Sep; 106(9):1756-60; discussion 1761. PubMed ID: 10485547
[TBL] [Abstract][Full Text] [Related]
17. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma.
Shields CL; Naseripour M; Shields JA
Am J Ophthalmol; 2002 May; 133(5):601-6. PubMed ID: 11992855
[TBL] [Abstract][Full Text] [Related]
18. Use of mitomycin C in the treatment of conjunctival primary acquired melanosis with atypia.
Frucht-Pery J; Pe'er J
Arch Ophthalmol; 1996 Oct; 114(10):1261-4. PubMed ID: 8859090
[TBL] [Abstract][Full Text] [Related]
19. Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.
Cid-Bertomeu P; Huerva V
Surv Ophthalmol; 2022; 67(5):1391-1404. PubMed ID: 35278438
[TBL] [Abstract][Full Text] [Related]
20. Topical mitomycin treatment for primary acquired melanosis of the conjunctiva.
Yuen VH; Jordan DR; Brownstein S; Dorey MW
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):149-51. PubMed ID: 12644763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
